Symbols / ATHXQ $0.00 +0.00% Athersys, Inc.

Healthcare • Biotechnology • United States • PNK
ATHXQ Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country PNK · United States
Market Cap 6.17K
Enterprise Value 17.56M
Income -37.51M
Sales 80.00K
FCF (ttm) -25.45M
Book/sh -1.36
Cash/sh 0.02
Employees 24
Insider 10d —
IPO Jun 12, 2007
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG -5.38
P/S 0.08
P/B -0.00
P/C —
EV/EBITDA -0.62
EV/Sales 219.46
Quick Ratio 0.03
Current Ratio 0.06
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -16.50
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-16
Earnings (prior) 2023-11-16
ROA -83.56%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin -359.09%
Profit Margin 0.00%
Shs Outstand 61.72M
Shs Float 61.65M
Insider Own 0.00%
Instit Own 0.00%
Short Float 3.78%
Short Ratio 3.32
Short Interest 993.20K
52W High 0.00
vs 52W High 0.00%
52W Low 0.00
vs 52W Low 900.00%
Beta 50.90
Impl. Vol. —
Rel Volume 497.76
Avg Volume 33.00
Volume 16.43K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%
About

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-7.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-03-06 init Alliance Global Partners — → Buy $6
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2022-12-31 2021-12-31
Total Revenue
5.33
-3.43%
5.51
Operating Revenue
5.33
-3.43%
5.51
Operating Expense
82.33
-11.06%
92.57
Research And Development
65.03
-8.51%
71.08
Selling General And Administration
15.88
-20.84%
20.07
General And Administrative Expense
15.88
-20.84%
20.07
Salaries And Wages
3.17
-35.57%
4.91
Other Gand A
12.72
-16.06%
15.15
Total Expenses
82.33
-11.06%
92.57
Operating Income
-77.01
+11.54%
-87.06
Total Operating Income As Reported
-77.01
+11.54%
-87.06
EBITDA
-75.59
+11.73%
-85.63
Normalized EBITDA
-79.79
+6.83%
-85.63
Reconciled Depreciation
1.42
-0.49%
1.43
EBIT
-77.01
+11.54%
-87.06
Total Unusual Items
4.20
—
Total Unusual Items Excluding Goodwill
4.20
—
Net Income
-72.53
+16.58%
-86.95
Pretax Income
-72.53
+16.58%
-86.95
Other Income Expense
4.47
+4244.66%
0.10
Other Non Operating Income Expenses
0.28
+169.90%
0.10
Gain On Sale Of Security
4.20
—
Tax Rate For Calcs
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
Net Income Including Noncontrolling Interests
-72.53
+16.58%
-86.95
Net Income From Continuing Operation Net Minority Interest
-72.53
+16.58%
-86.95
Net Income From Continuing And Discontinued Operation
-72.53
+16.58%
-86.95
Net Income Continuous Operations
-72.53
+16.58%
-86.95
Normalized Income
-76.73
+11.76%
-86.95
Net Income Common Stockholders
-72.53
+16.58%
-86.95
Diluted EPS
-6.07
-1456.41%
-0.39
Basic EPS
-6.07
-1456.41%
-0.39
Basic Average Shares
11.95
-94.67%
224.27
Diluted Average Shares
11.95
-94.67%
224.27
Diluted NI Availto Com Stockholders
-72.53
+16.58%
-86.95
Depreciation Amortization Depletion Income Statement
1.42
-0.49%
1.43
Depreciation And Amortization In Income Statement
1.42
-0.49%
1.43
Depreciation Income Statement
1.42
-0.49%
1.43
Line Item Trend 2022-12-31 2021-12-31
Total Assets
27.73
-53.92%
60.18
Current Assets
13.54
-70.59%
46.03
Cash Cash Equivalents And Short Term Investments
9.04
-75.84%
37.41
Cash And Cash Equivalents
9.04
-75.84%
37.41
Receivables
0.72
-83.78%
4.41
Accounts Receivable
0.72
-49.36%
1.41
Other Receivables
—
3.00
Prepaid Assets
2.75
-3.98%
2.86
Other Current Assets
1.03
-23.12%
1.34
Total Non Current Assets
14.20
+0.28%
14.16
Net PPE
12.06
-4.68%
12.65
Gross PPE
21.67
-4.84%
22.77
Accumulated Depreciation
-9.61
+5.03%
-10.12
Machinery Furniture Equipment
3.93
-1.65%
4.00
Other Properties
17.73
-5.51%
18.77
Non Current Prepaid Assets
2.14
+41.93%
1.50
Other Non Current Assets
2.14
+41.93%
1.50
Total Liabilities Net Minority Interest
51.58
+17.73%
43.81
Current Liabilities
38.44
+28.74%
29.86
Payables And Accrued Expenses
36.07
+68.75%
21.38
Payables
27.77
+64.29%
16.90
Accounts Payable
27.77
+64.29%
16.90
Current Accrued Expenses
8.31
+85.59%
4.48
Pensionand Other Post Retirement Benefit Plans Current
1.09
-73.63%
4.13
Current Debt And Capital Lease Obligation
0.75
-26.21%
1.01
Current Capital Lease Obligation
0.75
-26.21%
1.01
Current Deferred Liabilities
0.00
-100.00%
3.34
Current Deferred Revenue
0.00
-100.00%
3.34
Other Current Liabilities
0.53
—
Total Non Current Liabilities Net Minority Interest
13.14
-5.85%
13.95
Long Term Debt And Capital Lease Obligation
7.94
-9.32%
8.76
Long Term Capital Lease Obligation
7.94
-9.32%
8.76
Non Current Deferred Liabilities
5.20
+0.00%
5.20
Non Current Deferred Revenue
5.20
+0.00%
5.20
Stockholders Equity
-23.85
-245.71%
16.37
Common Stock Equity
-23.85
-245.71%
16.37
Capital Stock
0.02
+80.00%
0.01
Common Stock
0.02
+80.00%
0.01
Preferred Stock
0.00
0.00
Share Issued
17.99
+85.16%
9.71
Ordinary Shares Number
17.99
+85.16%
9.71
Additional Paid In Capital
632.01
+5.39%
599.70
Retained Earnings
-655.88
-12.43%
-583.34
Total Equity Gross Minority Interest
-23.85
-245.71%
16.37
Total Capitalization
-23.85
-245.71%
16.37
Working Capital
-24.91
-254.08%
16.17
Invested Capital
-23.85
-245.71%
16.37
Total Debt
8.69
-11.07%
9.77
Capital Lease Obligations
8.69
-11.07%
9.77
Net Tangible Assets
-23.85
-245.71%
16.37
Tangible Book Value
-23.85
-245.71%
16.37
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
-58.95
+22.62%
-76.19
Cash Flow From Continuing Operating Activities
-58.95
+22.62%
-76.19
Net Income From Continuing Operations
-72.53
+16.58%
-86.95
Depreciation Amortization Depletion
1.42
-0.49%
1.43
Depreciation
1.42
-0.49%
1.43
Depreciation And Amortization
1.42
-0.49%
1.43
Other Non Cash Items
—
0.23
Stock Based Compensation
6.20
-27.50%
8.56
Asset Impairment Charge
7.24
0.00
Operating Gains Losses
-4.23
—
Gain Loss On Investment Securities
-4.20
—
Change In Working Capital
2.95
+434.42%
0.55
Change In Receivables
3.70
+185.55%
-4.33
Changes In Account Receivables
3.70
+185.55%
-4.33
Change In Prepaid Assets
2.09
+230.28%
-1.60
Change In Payables And Accrued Expense
0.50
-84.45%
3.21
Change In Payable
0.50
-84.45%
3.21
Change In Account Payable
0.50
-84.45%
3.21
Change In Other Working Capital
-3.34
-202.05%
3.27
Investing Cash Flow
-0.26
+80.74%
-1.36
Cash Flow From Continuing Investing Activities
-0.26
+80.74%
-1.36
Net PPE Purchase And Sale
-0.26
+80.74%
-1.36
Purchase Of PPE
-0.40
+70.81%
-1.36
Sale Of PPE
0.14
0.00
Capital Expenditure
-0.40
+70.81%
-1.36
Financing Cash Flow
30.84
-51.36%
63.41
Cash Flow From Continuing Financing Activities
30.84
-51.36%
63.41
Net Common Stock Issuance
31.02
-51.73%
64.26
Proceeds From Stock Option Exercised
0.00
0.00
Net Other Financing Charges
-0.18
+79.11%
-0.86
Changes In Cash
-28.37
-100.64%
-14.14
Beginning Cash Position
37.41
-27.43%
51.55
End Cash Position
9.04
-75.84%
37.41
Free Cash Flow
-59.35
+23.47%
-77.55
Common Stock Issuance
31.02
-51.73%
64.26
Issuance Of Capital Stock
31.02
-51.73%
64.26
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category